Viewing Study NCT07117851


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-01-19 @ 11:12 AM
Study NCT ID: NCT07117851
Status: RECRUITING
Last Update Posted: 2025-08-12
First Post: 2025-08-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's Disease
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module